<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38504">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01909622</url>
  </required_header>
  <id_info>
    <org_study_id>VDFORT</org_study_id>
    <nct_id>NCT01909622</nct_id>
  </id_info>
  <brief_title>Trial of Vitamin D Fortified Milk</brief_title>
  <official_title>A Randomized Trial of Milk Fortified With Vitamin D in Colombia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <authority>Colombia: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prevalence of VDD is high worldwide, even in sunbathed equatorial regions where it had not
      been suspected before. The most cost-effective method for reducing population-wide VDD is
      through fortification of commonly consumed foods. Nevertheless, the efficacy of
      fortification varies by dose, duration, and population characteristics; and it is currently
      unknown whether it could be an efficacious public health intervention to curb the VDD
      epidemic among children living in tropical areas. We propose to conduct a randomized,
      controlled, double blind trial to assess the effect of vitamin D3 fortification of milk on
      serum 25-hydroxyvitamin D concentrations in school-age children and their mothers in Bogot√°,
      Colombia. Eighty families with a child participating in an ongoing cohort study will be
      randomized to receive one liter per day of either skim milk fortified with 600 IU vitamin D3
      per 250mL or unfortified skim milk for a six-week period.  Caregivers will be instructed to
      give the index child two cups of milk per day and to distribute the remaining milk to the
      rest of the family. We will measure serum 25(OH)D concentrations of the children and mothers
      at baseline and at the end of the intervention period.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Serum concentrations of 25-OH vitamin D</measure>
    <time_frame>up to 6 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>25-hydroxyvitamin D Serum Concentrations</condition>
  <arm_group>
    <arm_group_label>Vitamin D-fortified milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Skim milk fortified with 600 IU vitamin D3 / 250 mL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D-unfortified milk</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Unfortified skim milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <arm_group_label>Vitamin D-fortified milk</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>No vitamin D</intervention_name>
    <arm_group_label>Vitamin D-unfortified milk</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 144 and 174 completed months by the time of enrollment.

          2. Intention to stay in the city for the next six weeks.

          3. Children living with their biological mothers.

          4. Families own a refrigerator.

        Exclusion Criteria:

          1. History of illness involving calcium or bone metabolism, including stones of the
             urinary tract.

          2. Currently taking vitamin D supplements as treatment of any disease.

          3. Receiving immunosuppressive therapy (oral corticosteroids, chemotherapy) during the
             previous year.

          4. Known history of lactose intolerance or other contra-indications or aversion to milk
             intake.

          5. Known hypercalcemia.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>144 Months</minimum_age>
    <maximum_age>174 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mercedes Mora, MSc, RD</last_name>
    <role>Study Director</role>
    <affiliation>FINUSAD - Foundation for Research in Nutrition and Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henry Oliveros, MD, MSc</last_name>
    <role>Study Director</role>
    <affiliation>University of La Sabana</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mercedes Mora-Plazas, MSc, RD</last_name>
    <email>mmorap@unal.edu.co</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Henry Oliveros, MD, MSc</last_name>
    <email>oliveros.henry@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>FINUSAD - Foundation for Research in Nutrition and Health</name>
      <address>
        <city>Bogota</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mercedes Mora-Plazas, MSc, RD</last_name>
      <email>mmorap@unal.edu.co</email>
    </contact>
    <investigator>
      <last_name>Mercedes Mora-Plazas, MSc, RD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of La Sabana</name>
      <address>
        <city>Chia</city>
        <country>Colombia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henry Oliveros, MD, MSc</last_name>
      <email>oliveros.henry@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Henry Oliveros, MD, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 25, 2013</lastchanged_date>
  <firstreceived_date>July 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Eduardo Villamor</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Milk fortification</keyword>
  <keyword>Children</keyword>
  <keyword>Colombia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
